USE OF PEPTIDEALDEHYDE INHIBITOR FOR BLOCKING UROKINASE MEDIATED PROTEOLYTIC DEGRADATION IN THE FRONT SEGMENT OF THE EYE

• 1. KPNB1抑制剂和蛋白降解途径抑制剂在制备抗肿瘤药物中的应用 [P] . 中国专利： CN109718378B . 2021.08.10
• 2. KPNB1抑制剂和蛋白降解途径抑制剂在制备抗肿瘤药物中的应用 [P] . 中国专利： CN109718378A . 2019-05-07
• 3. USE OF PEPTIDEALDEHYDE INHIBITOR FOR BLOCKING UROKINASE MEDIATED PROTEOLYTIC DEGRADATION IN THE FRONT SEGMENT OF THE EYE [P] . HU0700770A2 . 2009-08-28

  机译： 肽醛抑制剂在阻断眼前节中尿激酶介导的蛋白降解中的应用

• 4. USE OF PEPTIDEALDEHYDE INHIBITOR FOR BLOCKING UROKINASE MEDIATED PROTEOLYTIC DEGRADATION IN THE FRONT SEGMENT OF THE EYE [P] . HU0700770D0 . 2008-02-28

  机译： 肽醛抑制剂在阻断眼前节中尿激酶介导的蛋白降解中的应用

• 5. Trivalent thrombin inhibitor comprising (S subsite blocking segment)-(S' subsite blocking segment)-(fibrinogen recognition exosite blocking segment) [P] . NZ503669A . 2001-09-28

  机译： 三价凝血酶抑制剂，包含（S亚位点阻断段）-（S'亚位点阻断段）-（纤维蛋白原识别异位阻断段）

• 1. The novel anti-tumour agent oxamflatin differntially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity [J] . Anthony E. Dear, Robert L. Medcalf Biochimica et biophysica acta. Gene structure and expression . 2000,第1期
• 2. GP330 ON TYPE II PNEUMOCYTES MEDIATES ENDOCYTOSIS LEADING TO DEGRADATION OF PRO-UROKINASE, PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX [J] . Stefansson S., Henkin J., Mallampalli RK., Journal of Cell Science . 1995,第Pta6期
• 3. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex. [J] . Stefansson S, Kounnas MZ, Henkin J, Journal of Cell Science . 1995,第Pta6期
• 4. In vivo degradation behavior of PDC multiblock copolymers containing poly(p-dioxanone) hard segments and crystallizable poly(ε-caprolactone) switching segments [C] . B. Hiebl, K. Kratz, R. Fuhrmann Materials Research Society Symposium . 2009
• 5. Matrix Metalloproteinase-7 Degradation of Fetuin Blocks Fetuin-Mediated Inhibition of Mineralization [D] . Rezaei, Reyhaneh 2013
• 6. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator its type-1 inhibitor and urokinase-mediated matrix degradation [O] . 1991
• 7. Introduction of an RRHR motif into chicken urokinase-type plasminogen activator (ch-uPA) confers sensitivity to plasminogen activator inhibitor (PAI)-1 and PAI-2 and allows ch-uPA-mediated extracellular matrix degradation to be controlled by PAI-1 [O] . Sipley, John D., Alexander, Daniela S., Testa, Jacqueline E., 1997

• 1. Inhibitor RNA blocks the protein translation mediated by hepatitis C virus internal ribosome entry site in vivo [J] . Xue-SongLiang ,Jian-QiLian ,Yong-XingZhou . 世界胃肠病学杂志：英文版 . 2004,第5期
• 2. Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells [J] . Zhang Heng ,Huang He ,Feng Xing . 解剖学杂志 . 2021,第S01期
• 3. 尿激酶型溶酶原激活剂单克隆抗体原的生产及其在抗原纯化中的应用重组人尿激酶原纯化中浓缩方法的比较 [C] . . 中国微生物学会生物产业发展中热点问题研讨会 . 1998
• 4. 向日葵胰蛋白酶抑制剂SFTI-1在大肠杆菌中由内含肽Intein介导的表达 [A] . 张威 . 2010